Scientific Advisory Board Contact News Investors Bioasis is dedicated to delivering hope to patients suffering with neurological diseases and disorders. Our breakthrough science focuses on transporting medicines across the blood-brain barrier, providing a path to hundreds of previously untreatable diseases of the central nervous system. Our Mission Meet Bioasis Bioasis General Annual Meeting December 16, 2021 Bioasis will host Annual General Meeting of shareholders on Thursday December 16, 2021, at 11:00 a.m. (Eastern standard time) at the offices of Marcum LLP, 555 Long Wharf Dr. 8th floor, New Haven, CT 06511, USA. To access the meeting by conference call, dial toll-free at 1-800-319-4610 within Canada or USA (or toll at +1-604-638-5340 if outside North America). Callers should dial-in 5-10 minutes prior to the scheduled start time and simply ask to join the call. To access the meeting by webcast, visit: webcast. In light of the ongoing public health concerns related to COVID-19, and in order to mitigate potential risks to the health and safety of the Company’s shareholders, employees, communities and other stakeholders, the Company is encouraging shareholders and others not to attend the meeting in person. Latest News Bioasis Announces Annual General Meeting Details Nov. 29, 2021 Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2021 Oct. 28, 2021 Bioasis to Attend Upcoming Industry Conferences Sep. 30, 2021 More News Discovery Development Programs Alliances Contact Policies © 2021 Bioasis Technologies, Inc.

Scientific Advisory Board Contact News Investors Contact Bioasis Technologies Inc. United States 157 Church Street, 19th floor New Haven, CT 06510 Canada 4170 Still Creek Drive, Suite 200 Burnaby, BC V5C 6C6 1.203.533.7082 Info@bioasis.us Media & Investors Contact Deborah Rathjen 1.203.533.7082 investors@bioasis.us Graeme Dick 1.403.561.8989 graeme@colwellcapital.com General Inquiries Please contact Info@bioasis.us Contact Policies © 2021 Bioasis Technologies, Inc.